Pfizer on OTC sale
This article was originally published in The Tan Sheet
Executive Summary
Bids for Pfizer's OTC division during a June 6 auction reportedly topped $15 bil., while bidders included GlaxoSmithKline, Johnson & Johnson and Reckett Benckiser. Pfizer says it is still maintaining the option of spinning the division off to shareholders 1("The Tan Sheet" May 29, 2006 p. 6 ). "The review is continuing, and we will be announcing which of the strategic options [we choose] in the third quarter," a Pfizer spokesman said...
You may also be interested in...
Pfizer Weighs Options For OTC Division As Investors Line Up For Purchase
While Pfizer considers whether to sell its Consumer Healthcare unit or spin it off to shareholders, potential buyers are placing bids with an eye toward an early June deadline
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.